Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Burnet

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|April 30, 2005
Radiotherapy for the futureBleddyn Jones, Neil Burnet
Der Radiologe|August 9, 2018
["Only a planning …"]Stefan Delorme, Ursula Nestle, Neil Burnet
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 19, 2002
Metastases from glioblastoma multiforme (GBM) are a rare but important eventKathryn Waite, Sally Old, Neil Burnet
BMJ Case Reports|May 27, 2014
Panhypopituitarism secondary to a solitary hypothalamic metastasisMark Ellul, Tobias Janowitz, Neil Burnet
BMC Medicine|August 3, 2022
Urinary symptoms and prostate cancer-the misconception that may be preventing earlier presentation and better survival outcomesVincent J Gnanapragasam, David Greenberg, Neil Burnet
BJR Case Reports|October 27, 2018
The use of <sup>11</sup>carbon methionine positron emission tomography (PET) imaging to enhance radiotherapy planning in the treatment of a giant, invasive pituitary adenomaNicolette Taku, Olympia Koulouri, Daniel Scoffings, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 3, 2022
In regard to Van Marlen: FLASH radiotherapy: Considerations for multibeam and hypofractionation dose deliveryRanald Mackay, Neil Burnet, Matthew Lowe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 26, 2021
FLASH radiotherapy: Considerations for multibeam and hypofractionation dose deliveryRanald MacKay, Neil Burnet, Matthew Lowe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2024
Incidence of alopecia in brain tumour patients treated with pencil scanning proton therapy and validation of existing NTCP modelsSimona Gaito, Laura Cella, Anna France, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I studyMark R Albertella, Paul M Loadman, Philip H Jones, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|April 30, 2005
Radiotherapy for the futureBleddyn Jones, Neil Burnet
Der Radiologe|August 9, 2018
["Only a planning …"]Stefan Delorme, Ursula Nestle, Neil Burnet
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 19, 2002
Metastases from glioblastoma multiforme (GBM) are a rare but important eventKathryn Waite, Sally Old, Neil Burnet
BMJ Case Reports|May 27, 2014
Panhypopituitarism secondary to a solitary hypothalamic metastasisMark Ellul, Tobias Janowitz, Neil Burnet
BMC Medicine|August 3, 2022
Urinary symptoms and prostate cancer-the misconception that may be preventing earlier presentation and better survival outcomesVincent J Gnanapragasam, David Greenberg, Neil Burnet
BJR Case Reports|October 27, 2018
The use of <sup>11</sup>carbon methionine positron emission tomography (PET) imaging to enhance radiotherapy planning in the treatment of a giant, invasive pituitary adenomaNicolette Taku, Olympia Koulouri, Daniel Scoffings, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 3, 2022
In regard to Van Marlen: FLASH radiotherapy: Considerations for multibeam and hypofractionation dose deliveryRanald Mackay, Neil Burnet, Matthew Lowe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 26, 2021
FLASH radiotherapy: Considerations for multibeam and hypofractionation dose deliveryRanald MacKay, Neil Burnet, Matthew Lowe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2024
Incidence of alopecia in brain tumour patients treated with pencil scanning proton therapy and validation of existing NTCP modelsSimona Gaito, Laura Cella, Anna France, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Hypoxia-selective targeting by the bioreductive prodrug AQ4N in patients with solid tumors: results of a phase I studyMark R Albertella, Paul M Loadman, Philip H Jones, et al.
Pageof 3